Narrow search
Showing 1 - 10 of 13,963
Cover Image
The Effects of Detailing on Prescribing Decisions Under Quality Uncertainty
Ching, Andrew T.; Ishihara, Masakazu - 2010
Motivated by recent empirical findings on the relationship between new clinical evidence and the effectiveness of detailing, this paper develops a new structural model of detailing and prescribing decisions under the environment where both manufacturers and physicians are uncertain about drug...
Persistent link: https://www.econbiz.de/10014048404
Cover Image
The generics paradox revisited : empirical evidence from regulated markets
Vandoros, Sotiris; Kanavos, Panos - In: Applied economics 45 (2013) 22/24, pp. 3230-3239
Persistent link: https://www.econbiz.de/10010345456
Cover Image
Unpacking the effects of adverse regulatory events : Evidence from pharmaceutical relabeling
Higgins, Matthew J.; Yan, Xin; Chatterjee, Chirantan - In: Research policy : policy, management and economic … 50 (2021) 1, pp. 1-15
Persistent link: https://www.econbiz.de/10012663313
Cover Image
Pharmaceutical pricing in emerging markets : effects of income, competition, and procurement
Danzon, Patricia Munch; Mulcahy, Andrew W.; Towse, Adrian K. - In: Health economics 24 (2015) 2, pp. 238-252
Persistent link: https://www.econbiz.de/10011317852
Cover Image
Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market : evidence from Taiwan
Liu, Ya Ming; Hsieh, Chee-Ruey - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 241-275
Persistent link: https://www.econbiz.de/10010345585
Cover Image
Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market
Bokhari, Farasat A. S.; Yan, Weijie - 2020
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
Cover Image
Pharmaceutical prices: the impact of the launch strategy : an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012103333
Cover Image
Pharmaceutical prices : the impact of the launch strategy - an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019 - This Version: September 24, 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012119750
Cover Image
The effects of detailing on prescribing decisions under quality uncertainty
Ching, Andrew; Ishihara, Masakazu - In: Quantitative marketing and economics : QME 8 (2010) 2, pp. 123-165
Persistent link: https://www.econbiz.de/10003977328
Cover Image
Pharmaceutical innovation and health outcomes : empirical evidence from Taiwan
Hsieh, Chee-Ruey; Lo, Kuang-ta Vance; Hong, Yichen; … - In: Pharmaceutical innovation : incentives, competition, …, (pp. 242-261). 2007
Persistent link: https://www.econbiz.de/10003499023